0001179110-20-010063.txt : 20201001
0001179110-20-010063.hdr.sgml : 20201001
20201001171707
ACCESSION NUMBER: 0001179110-20-010063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201001
FILED AS OF DATE: 20201001
DATE AS OF CHANGE: 20201001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gutierrez-Ramos Jose-Carlos
CENTRAL INDEX KEY: 0001667657
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50797
FILM NUMBER: 201217088
MAIL ADDRESS:
STREET 1: C/O MOMENTA PHARMACEUTICALS, INC.
STREET 2: 675 WEST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER NAME:
FORMER CONFORMED NAME: Guiterrez-Ramos Jose Carlos
DATE OF NAME CHANGE: 20160222
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 491-9700
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
FORM 4 -
X0306
4
2020-10-01
1
0001235010
MOMENTA PHARMACEUTICALS INC
MNTA
0001667657
Gutierrez-Ramos Jose-Carlos
C/O MOMENTA PHARMACEUTICALS, INC
301 BINNEY STREET
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (Right to Buy)
8.59
2020-10-01
4
D
0
20000
D
2026-03-09
Common Stock
20000
0
D
Stock Option (Right to Buy)
17.20
2020-10-01
4
D
0
11207
D
2027-06-20
Common Stock
11207
0
D
Stock Option (Right to Buy)
22.30
2020-10-01
4
D
0
8855
D
2028-06-20
Common Stock
8855
0
D
Stock Option (Right to Buy)
12.64
2020-10-01
4
D
0
25000
D
2029-06-19
Common Stock
25000
0
D
Stock Option (Right to Buy)
38.09
2020-10-01
4
D
0
25000
D
2030-06-23
Common Stock
25000
0
D
Reflects disposition of options to acquire shares of Issuer common stock (each, an "Issuer Option") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the "Effective Time"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option.
/s/ R. Mark Chamberlin as attorney in fact
2020-10-01